{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:27:11Z","timestamp":1648787231299},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/mjt.0b013e3182456a61","type":"journal-article","created":{"date-parts":[[2012,4,8]],"date-time":"2012-04-08T06:59:51Z","timestamp":1333868391000},"page":"174-179","source":"Crossref","is-referenced-by-count":5,"title":["Decreased Plasma Methionine\u2013Enkephalin Levels in Cluster Headache Patients"],"prefix":"10.1097","volume":"19","author":[{"given":"Aron D.","family":"Mosnaim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricio","family":"Maturana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion E.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/POR.S13363","article-title":"Biological correlates of migraine and cluster headaches: an overview of their potential use in diagnosis and treatment.","volume":"1","author":"Mosnaim","year":"2010","journal-title":"Pragm Observ Res"},{"key":"R4-4-20210202","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1526-4610.1989.hed2906368.x","article-title":". Endogenous opioid-like peptides in headache. An overview.","volume":"29","author":"Mosnaim","year":"1989","journal-title":"Headache"},{"key":"R6-4-20210202","first-page":"259","article-title":". Plasma methionine-enkephalin levels.","volume":"25","author":"Mosnaim","year":"1985","journal-title":"A biological marker for migraine Headache"},{"key":"R7-4-20210202","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1526-4610.1986.hed2606278.x","article-title":". Plasma methionine-enkephalin. Increased levels during a migraine episode.","volume":"26","author":"Mosnaim","year":"1986","journal-title":"Headache"},{"key":"R9-4-20210202","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1526-4610.1987.hed2706325.x","article-title":". Plasma and platelet methionine-enkephalin levels in chronic cluster patients during an acute headache episode.","volume":"27","author":"Mosnaim","year":"1987","journal-title":"Headache"},{"key":"R10-4-20210202","first-page":"79","article-title":". Plasma degradation of methionine-enkephalin by cluster headache patients. In vitro studies.","volume":"1","author":"Mosnaim","year":"1990","journal-title":"Headache Quart Curr Treatment Res"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.mjt.0000134785.42464.17","article-title":". Inhibition of human plasma leucine-enkephalin aminopeptidase hydrolysis by various endogenous peptides and a select number of clinically used drugs.","volume":"11","author":"Mosnaim","year":"2004","journal-title":"Am J Therap"},{"key":"R12-4-20210202","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1468-2982.2005.01006.x","article-title":". Peripheral levels of BDNF and NGF in primary headaches.","volume":"26","author":"Blandini","year":"2006","journal-title":"Cephalalgia"},{"key":"R13-4-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jpain.2007.05.002","article-title":". Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome.","volume":"8","author":"Sarchielli","year":"2007","journal-title":"J Pain"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1526-4610.1998.3806465.x","article-title":". Cytokines and migraine: increase of IL-5 and IL-4 plasma levels.","volume":"38","author":"Munno","year":"1998","journal-title":"Headache"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jneuroim.2005.10.005","article-title":". The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine.","volume":"171","author":"Fidan","year":"2006","journal-title":"J Neuroimmunol"},{"key":"R16-4-20210202","first-page":"34","article-title":"Biochemical and immunological studies in migraine and cluster headaches.","volume":"4","author":"Mosnaim","year":"1994","journal-title":"Curr Treatment Res"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1468-2982.1998.1804197.x","article-title":". Flow cytometric analysis of lymphocytes subsets in migraine patients during and outside of an acute headache attack.","volume":"18","author":"Mosnaim","year":"1998","journal-title":"Cephalalgia"},{"key":"R18-4-20210202","first-page":"245","article-title":". An overview on immune system and migraine.","volume":"11","author":"Bruno","year":"2007","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0889-1591(92)90057-U","article-title":". Enhancement of human natural killer cell activity by opioid peptides: similar response to methionine-enkephalin and B-endorphin.","volume":"6","author":"Puente","year":"1992","journal-title":"Brain Behav Immun"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0006-3223(91)91301-7","article-title":". Plasma methionine-enkephalin in posttraumatic stress disorder.","volume":"29","author":"Wolf","year":"1991","journal-title":"Biol Psychiat"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/bega.2000.0109","article-title":"Pruritus and fatigue in primary biliary cirrhosis.","volume":"14","author":"Bergasa","year":"2000","journal-title":"Best Practice Res Clin Gastroenterol"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00045391-200007030-00006","article-title":". Degradation kinetics of leucine-enkephalin by plasma samples from healthy controls and various patient populations: in vitro drug effects.","volume":"7","author":"Mosnaim","year":"2000","journal-title":"Am J Ther"},{"key":"R26-4-20210202","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000066781","article-title":". In vitro human plasma leucine-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure.","volume":"67","author":"Mosnaim","year":"2003","journal-title":"Pharmacology"},{"key":"R27-4-20210202","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.mjt.0000134785.42464.17","article-title":". Inhibition of human plasma leucine-enkephalin aminopeptidase hydrolysis by various endogenous peptides and a select number of clinically used drugs.","volume":"11","author":"Mosnaim","year":"2004","journal-title":"Am J Therap"},{"key":"R28-4-20210202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.mjt.0000212897.20458.63","article-title":". Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents.","volume":"13","author":"Ranade","year":"2006","journal-title":"Am J Therap"},{"key":"R29-4-20210202","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/MJT.0b013e3181bbf6e9","article-title":"Bacitracin-sensitive aminopeptidase(s) degradation of methionine-enkephalin by human brain putamem and hippocampus preparations. Inhibition by phenothiazine drugs.","volume":"16","author":"Mosnaim","year":"2009","journal-title":"Am J Therap"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-201205000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:42:34Z","timestamp":1618036954000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201205000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3182456a61","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}